Pharmacists in Vadnais Heights, Minnesota


12 Pharmacists found in Vadnais Heights
male pharmacist

Anwar Muhammad Umar


Pharmacist - Pharmacotherapy
850 County Road E E, Vadnais Heights, MN 55127
651-486-7005    

female pharmacist

Carrie Bader, PHARM D


Pharmacist
975 County Road E E, Vadnais Heights, MN 55127
651-483-2776    

female pharmacist

Ms. Christine Koentopp, BPHARM


Pharmacist
3479 Centerville Rd, Vadnais Heights, MN 55127
651-645-7284    



male pharmacist

Corey Simmons


Pharmacist
850 County Road E E, Vadnais Heights, MN 55127
651-486-7005    

female pharmacist

Farhia Mursal, PHARM. D


Pharmacist
975 County Road E E, Vadnais Heights, MN 55127
651-483-9637    

female pharmacist

Mrs. Jessica Marie Arodi, PHARMACISST


Pharmacist
975 County Road E E, Vadnais Heights, MN 55127
651-483-2776     651-483-2776

male pharmacist

Jonathan Rechtiene, PHARM D


Pharmacist
850 County Road E E, Vadnais Heights, MN 55127
651-486-7005     651-486-7548

male pharmacist

Dr. Joseph Brandenburg, PHARMD


Pharmacist
975 County Road E E, Vadnais Heights, MN 55127
262-993-3002    

female pharmacist

Julia Ann-marie Rabey, PHARMD


Pharmacist
975 County Road E E, Vadnais Heights, MN 55127
651-483-2776    

female pharmacist

Marjan Sarah Khazaeli, PHARM.D., BCACP


Pharmacist
480 Highway 96 E, Vadnais Heights, MN 55127
651-326-5900    

male pharmacist

Nouh Gobena, RPH


Pharmacist
975 County Road E E, Vadnais Heights, MN 55127
651-483-2776    

male pharmacist

Dr. Rory Patrick Mclafferty, PHARM.D.


Pharmacist
975 County Road E E, Vadnais Heights, MN 55127
651-483-2776    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.